Showing results (161-170 of 214) with videos related to

Sort By:
Pageof 22
Cell Reports. Medicine|November 9, 2022
Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapyJonathan D Herman, Chuangqi Wang, John Stephen Burke, et al.
Nature Immunology|December 19, 2022
Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4+ T cell reservoirVincent H Wu, Jayme M L Nordin, Son Nguyen, et al.
The New England Journal of Medicine|October 4, 2008
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infectionGerd Fätkenheuer, Mark Nelson, Adriano Lazzarin, et al.
Nature Medicine|October 21, 2025
Safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies in healthy adults: a phase 1 trialPablo Tebas, Ami Patel, Joseph T Agnes, et al.
The Journal of Clinical Investigation|July 29, 2025
Factors associated with resistance of HIV-1 reservoir viruses to neutralization by autologous IgG antibodiesNatalie F McMyn, Joseph Varriale, Hanna W S Wu, et al.
The New England Journal of Medicine|September 15, 2021
Safety and Immunogenicity of an Anti-Zika Virus DNA VaccinePablo Tebas, Christine C Roberts, Kar Muthumani, et al.
The New England Journal of Medicine|March 7, 2014
Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIVPablo Tebas, David Stein, Winson W Tang, et al.
The Lancet. Respiratory Medicine|May 20, 2017
Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised studyJohn H Beigel, Pablo Tebas, Marie-Carmelle Elie-Turenne, et al.
The Journal of Clinical Investigation|June 19, 2018
HIV-1 latent reservoir size and diversity are stable following brief treatment interruptionD Brenda Salantes, Yu Zheng, Felicity Mampe, et al.
Pageof 22